Transparent corporate social responsibility ratings to help you change the world.
LEARN ABOUT A COMPANY'S SUSTAINABILITY
User login form 2012
SUBSCRIBE NOW, for all the benefits.
-
BENCHMARK companies'
sustainability in 12 sub-categories. -
ROLLBACK and view CSR ratings
over time (pro level). -
EXPORT customized search results
to Excel. -
VIEW companies' CSR sites and
underlying data from many sources.
ANNUAL PLAN, 4 MONTHS FREE
Profile unified block 2012
PROFILE TOOL
CSRHub user average |
EDIT | |
| PRIORITIES | ||
| Community | 2.6 | |
| Employees | 2.8 | |
| Environment | 3.7 | |
| Governance | 2.9 | |
SPECIAL ISSUES
No special issues for this profile.
![]() |
Endo Pharmaceuticals Holdings Inc. |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Endo Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain. Its products include LIDODERM, PERCOCET and PERCODAN tablets; FROVA tablets; OPANA tablets for the relief of moderate-to-severe acute pain where the use of an opioid is appropriate; OPANA ER tablets; and VOLTAREN gel a nonsteroidal anti-inflammatory drug indicated for the relief of the pain of osteoarthritis of joints amenable to topical treatment. The company markets its branded pharmaceutical products to physicians in pain management, neurology, surgery, oncology, and primary care.
Basic corporate social responsibility ratings
Data sources for this company
Ratings historySubcategory CSR ratings
Special issues that affect this company
Original data values
Flags
Name variants
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||













